Buscar
Mostrando ítems 41-50 de 461
Blood and intragraft CD27 gene expression in cardiac transplant recipients
(Elsevier B.V., 2003-04-01)
The present study investigated gene expression of costimulatory molecule CD27 in relation to the occurrence of acute cardiac rejection. CD27 transcripts were measured by means of quantitative competitive reverse ...
Rechazo humoral en trasplante cardíaco: Comunicación de dos casos
(Sociedad Médica de Santiago, 2000)
Conversion From Calcineurin Inhibitors to Belatacept in HLA-sensitized Kidney Transplant Recipients With Low-level Donor-specific Antibodies
(2019)
Background: Belatacept could be the treatment of choice in renal-transplant recipients with renal dysfunction attributed to calcineurin inhibitor (CNI) nephrotoxicity. Few studies have described its use in patients with ...
Acute cellular rejection in small-bowel transplantation impairs NCR+ innate lymphoid cell subpopulation 3/interleukin 22 axis
(Elsevier Science, 2020-06)
Acute cellular rejection (ACR) remains as one of the main causes of graft loss and death in intestinal transplant (ITx) patients. ACR promotes intestinal injury, disruption of the mucosal barrier, bacterial translocation, ...
Survival time to biopsy-proven acute rejection and tacrolimus adverse drug reactions in pediatric liver transplantation
(Lippincott Williams, 2018-08)
Background: Despite advances in surgical procedures and the optimization of immunosuppressive therapies in pediatric liver transplantation, acute rejection (AR) and serious adverse drug reaction (ADR) to tacrolimus still ...
Avaliação da incidência de rejeição aguda em uma coorte retrospectiva de pacientes retransplantados renais submetidos a regimes de indução com timoglobulina 3mg/kg versus 5mg/kg: análise comparativa
(Universidade Federal de São Paulo (UNIFESP), 2021)
Optimizing antithymocyte globulin (rATG) dosage is critical for high immunological risk patients undergoing a repeat kidney transplant. This natural retrospective cohort study compared clinical outcomes of two successive ...
Late Acute Humoral Rejection in Low-Risk Renal Transplant Recipients Induced With an Interleukin-2 Receptor Antagonist and Maintained With Standard Therapy: Preliminary Communication
(ELSEVIER SCIENCE INC, 2011)
Low-risk renal transplant recipients treated with standard immunosuppressive therapy including interleukin-2 receptor (IL-2R) antagonist show a low incidence of early rejection episodes but few reports have examined the ...